ロード中...
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
BACKGROUND: Clinical trials evaluating anti-CD20-mediated B-cell depletion in multiple sclerosis (MS) and neuromyelitis optica (NMO) generated encouraging results. Our recent studies in the MS model experimental autoimmune encephalomyelitis (EAE) attributed clinical benefit to extinction of activate...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3214191/ https://ncbi.nlm.nih.gov/pubmed/22027448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-2094-8-146 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|